THURSDAY, Jan. 21, 2021 (HealthDay News) — Despite scattered media reports of severe allergic reactions to the Pfizer COVID-19 vaccine, a detailed analysis shows that such incidents are very rare, striking just 11 people for every million doses given. The study, compiled by researchers at the U.S. Centers for DiseaseContinue Reading

SATURDAY, Jan. 9, 2021 (HealthDay News) — A task force of allergists and immunologists recommends those administering the COVID-19 vaccine ask patients some key questions beforehand. While reactions to vaccines are extremely rare, the American College of Allergy, Asthma and Immunology (ACAAI) said anyone being vaccinated should be asked ifContinue Reading

FRIDAY, Jan. 8, 2021 (HealthDay News) — Most folks are familiar with the havoc that high pollen levels can wreak on their lungs, but new research suggests they can also exacerbate a painful pelvic condition in some people. “Our study provides evidence to suggest increased pollen counts may trigger symptomContinue Reading

WEDNESDAY, Jan. 6, 2021 (HealthDay News) — Cases of anaphylactic shock caused by COVID-19 vaccines are very rare, based on numbers from the first week and a half of vaccinations in the United States, federal public health officials said Wednesday. There have been 21 cases of anaphylaxis out of nearlyContinue Reading

WEDNESDAY, Oct. 7, 2020 (HealthDay News) — Everyone agrees about the good news — folks whose asthma is spurred on by allergies don’t appear to have an increased risk of life-threatening illness if they contract COVID-19. “Asthma has not risen as one of the top comorbid diseases for worse COVID-19Continue Reading

MONDAY, May 18, 2020 (HealthDay News) — Roughly 16 million Americans have chronic obstructive pulmonary disease (COPD), but only a fraction have access to a lifesaving treatment called pulmonary rehabilitation. COPD is a family of diseases, including emphysema and chronic bronchitis, that make breathing difficult and worsens over time. TheContinue Reading

SUNDAY, April 19, 2020 (HealthDay News) — Despite increased demand for inhalers in some parts of the United States, Americans with asthma shouldn’t ration their medications during the coronavirus pandemic, the American Lung Association says. Rescue inhalers are in short supply in some areas because hospitals are giving albuterol toContinue Reading

MONDAY, March 30, 2020 (HealthDay News) — As hospitals give more and more COVID-19 patients albuterol to help them breathe, people with asthma may have a hard time getting an inhaler. The American College of Allergy, Asthma and Immunology (ACAAI) said some areas of the United States are experiencing shortagesContinue Reading